Clinical Trial

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a single-dose, open-label, 2-cycle crossover design, comparing the pharmacokinetic parameters and safety of Inhaled Fentanyl Aerosol and intravenous fentanyl injection.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-04-23; most recent amendment 2025-09-24.
Status change: Not Yet Recruiting → Recruiting 2025-09-24
Trial Details
NCT Number NCT06953453
Lead Sponsor Lee's Pharmaceutical Limited
Conditions Cancer
Enrollment 100 participants
Start Date 2025-09-23
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-08-20 (estimated)
Updated on ClinicalTrials.gov 2025-09-25